Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Randomized Placebo-Controlled multicenter study to assess the efficacy, safety and tolerability of Oral Bacterial Extract for the prevention of wheezing lower respiratory tract illness
Breathe Easy Early ORBEX Study
Sponsor:University of Arizona
Enrolling:Male and Female Patients
Study Length:3 Years
IRB Number:AAAQ9156
U.S. Government ID:NCT02148796
Contact: Carmen Liriano: 212-305-6265 / crl58@cumc.columbia.edu
Additional Study Information:

The Breathe Easy Early ORBEX Study is a three -year study to identify if a daily capsule of Broncho-Vaxom may help prevent or delay young children from developing wheezing or asthma- like symptoms. Other studies have found that Broncho-Vaxom can help prevent upper respiratory infections and stimulate immune defenses, and has been safely and effectively used around the world. Broncho-Vaxom has not been approved yet in the United States however, it has been used safely by 43 million children in countries all over the world.

Do You Qualify?
Do you or anyone in your family have a history of asthma? Or, does your child under 17 months have eczema?YesNo
Submit
Cancel
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Carmen Liriano
Email: crl58@cumc.columbia.edu
Phone: 212-305-6265